Effect of thymosin alpha 1 on hypothalamic hormone release.
Milenkovic. L L; Lyson. K K; Aguila. M C MC; McCann. S M SM
Key Findings
- Thymosinâalphaâ1 inhibits TRH release from hypothalamic fragments at a minimal effective dose of 10â»ÂčÂčâŻM
- It also suppresses CRH and somatostatin release, but requires a higher dose of 10â»âčâŻM
- The peptideâs potency follows TRHâŻ>âŻCRHâŻ>âŻsomatostatin, matching earlier inâvivo findings on pituitary hormone drops
Practical Outcomes
- Tα1 might be able to blunt thyroidâstimulating and stressârelated hormone cascades, which could be attractive for those seeking to lower TSH or cortisol. Yet, because the data are from an inâvitro mouse model, thereâs no clear guidance on safe or effective human dosing, so itâs not ready for protocol changes without further research.
Summary
The study shows that the peptide thymosinâalphaâ1 can directly suppress the brainâs release of hormones that control the thyroid (TRH), stress (CRH) and growth hormone regulation (somatostatin) in a lab dish, and it does this at very tiny concentrations. However, the work was done on isolated mouse hypothalamus tissue, not in people, so we donât know how it translates to realâworld dosing or effects.
Abstract
Thymosin alpha 1 (T alpha 1) is a well-characterized immunopotentiating polypeptide originally isolated from calf thymus. We have recently shown in vivo, probable hypothalamic effects of T alpha 1 to decrease the release of the pituitary hormones, TSH, PRL and ACTH from the pituitary gland. Therefore, in the present study we evaluated the effect of the peptide on the release of hypothalamic regulatory hormones: thyrotropin-releasing hormone (TRH) and corticotropin-releasing hormone (CRH), as well as somatostatin (SRIH), from medial basal hypothalamic (MBH) fragments incubated in vitro. After a preliminary time-course study indicated that a 30-min incubation period was optimal, it was used for all the other experiments. At the end of the incubation the tissue was still able to respond to a depolarizing K+ concentration for 15 min by a 4-fold increase of TRH concentration compared to control basal release during the preceding 30 min. T alpha 1 was shown to inhibit the release of TRH and CRH from MBH fragments incubated in vitro with a minimal effective dose (MED) of 10(-11) M. SRIH and CRH release was also inhibited but the MED for these peptides was 10(-9) M. The relative responsiveness to the action of T alpha 1 was TRH greater than CRH, which was greater than SRIH. This correlated with our previous in vivo results for pituitary hormone release, except in the case of SRIH since we previously did not detect any significant effect of the peptide on growth hormone release. Finally, we evaluated the possible involvement of other neurotransmitters in the effect of T alpha 1 on TRH release.(ABSTRACT TRUNCATED AT 250 WORDS)
Study Information
pubmed
1992
1992-07-01T00:00:00.000Z
10.1159/000126292
18